Log In
Print
BCIQ
Print
Print this Print this
 

GPR17 antagonists

  Manage Alerts
Collapse Summary General Information
Company Omeros Corp.
DescriptionG protein-coupled receptor 17 (GPR17) antagonist
Molecular Target G protein-coupled receptor 17 (GPR17)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationMultiple sclerosis (MS)
Indication DetailsTreat multiple sclerosis (MS)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today